GlassScriptPhysician profile
Roselle Almeida
NPI 1720243645
$22,201.73
in general payments reported to CMS, 2019-2025
49 companies · $2,586 in 2025
The $2,586 reported for 2025 was more than what 80% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,288 · 2020: $710 · 2021: $1,284 · 2022: $1,583 · 2023: $1,855 · 2024: $12K · 2025: $2,586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,868 · Food and Beverage: $6,101 · Travel and Lodging: $1,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,867.98 |
| Food and Beverage | $6,100.83 |
| Travel and Lodging | $1,367.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,022.67 | 2023-2024 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $2,014.27 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $2,012.41 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Jazz Pharmaceuticals INC. | $921.29 | 2019-2025 | Xywav |
| Boehringer Ingelheim Pharmaceuticals, INC. | $769.36 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Mylan Specialty L.P. | $734.99 | 2019-2024 | Yupelri |
| Electromed, INC. | $658.43 | 2019-2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $610.42 | 2019-2025 | Dupixent |
| United Therapeutics Corporation | $411.26 | 2020-2025 | Tyvaso, Tyvaso |
| Mallinckrodt Hospital Products INC. | $385.87 | 2022-2025 | Acthar |
| Genzyme Corporation | $319.16 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $315.79 | 2021-2025 | Glassia, Cuvitru, Hyqvia |
| Genentech USA, INC. | $274.25 | 2019-2021 | |
| Philips North America LLC | $250.29 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Actelion Pharmaceuticals US, INC. | $231.46 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $213.24 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Grifols USA, LLC | $188.74 | 2022-2025 | Prolastin-C Liquid |
| Amgen INC. | $166.30 | 2021-2025 | Tezspire, Tavneos |
| Verona Pharma, INC. | $146.96 | 2025 | Ohtuvayre |
| Novartis Pharmaceuticals Corporation | $132.53 | 2019-2021 | |
| Insmed, INC. | $125.10 | 2023-2025 | Arikayce |
| Viatris Specialty LLC | $115.71 | 2025 | Yupelri |
| Inogen, INC. | $99.67 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Janssen Pharmaceuticals, INC | $97.22 | 2022-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $89.99 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $69.18 | 2019-2021 | |
| Lilly USA, LLC | $68.70 | 2025 | Zepbound |
| Sunovion Pharmaceuticals INC. | $60.44 | 2019 | |
| Harmony Biosciences LLC | $59.67 | 2023-2024 | Wakix |
| Alexion Pharmaceuticals, INC. | $56.49 | 2019-2025 | Ultomiris |
| Axsome Therapeutics, INC. | $50.81 | 2024-2025 | Sunosi |
| Merck Sharp & Dohme LLC | $46.29 | 2021-2023 | |
| Pulmonx Corporation | $46.23 | 2022 | |
| Ani Pharmaceuticals, INC. | $45.05 | 2024 | Purified Cortrophin Gel |
| Pfizer INC. | $41.65 | 2019-2023 | |
| Ambu INC. | $37.50 | 2021 | |
| Tactile Systems Technology INC | $37.47 | 2025 | Nimbl, Flexitouch Plus |
| Chiesi USA, INC. | $34.51 | 2025 | Cleviprex, Kengreal |
| Phathom Pharmaceuticals, INC. | $30.49 | 2025 | Voquezna |
| Resmed Corp | $25.78 | 2020-2021 | |
| Vifor Pharma, INC. | $25.74 | 2025 | Veltassa |
| Inspire Medical Systems, INC. | $24.30 | 2023 | Inspire |
| Shire North American Group INC | $24.21 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $23.53 | 2025 | Eliquis |
| Advanced Respiratory, INC | $20.94 | 2020 | |
| La Jolla Pharmaceutical Company | $18.76 | 2019 | |
| Adma Biomanufacturing LLC | $17.46 | 2021 | |
| Novo Nordisk INC | $15.34 | 2022 | |
| Livanova USA, INC. | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roselle Almeida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.